News & Press: Advocacy

SIS Comments on Humana’s Coverage Exclusions in Revised Headache and Occipital Neuralgia Policy

Monday, March 12, 2018  
Share |

On March 8, 2018, SIS again informed Humana that exclusions in the Humana coverage policy, “Headache and Occipital Neuralgia Treatments,” (policy number HGO-0455-012, revised January 25, 2018), are inconsistent with the evidence base.

Humana’s revised policy still excludes coverage for third occipital nerve (C2-3) denervation and radiofrequency neurotomy (RF) for its members, incorrectly considering these beneficial treatments to be experimental/investigational.

The recent SIS comment letter summarizes the available literature, citing 16 peer-reviewed medical articles that counter Humana’s policy, and offers Humana ongoing input and expertise in this matter. SIS previously addressed this issue with Humana.

Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2016 Spine Intervention Society Privacy Policy  ::  Legal